Loading stock data…
$97.03+2.58 (+2.74%)
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics.
BillionToOne, Inc. in the Healthcare sector is trading at $97.03 with a market capitalization of $4.7B. Wall Street consensus targets $129.00 (7 analysts), implying a +33.0% move over the next 12 months. The stock is currently 36% below its 52-week high of $150.44, remaining 1.7% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. Risk note: RSI 21 is oversold, raising the odds of a near-term bounce. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $109.45M↑ | $108.39M↑ | $96.05M↑ | $83.52M↑ | $66.57M |
| Gross Profit | $77.11M↓ | $79.10M↑ | $68.60M↑ | $58.42M↑ | $43.47M |
| Operating Income | $5.50M↓ | $17.83M↑ | $10.33M↑ | $9.63M↑ | -$1.63M |
| Net Income | $8.05M↓ | $17.97M↑ | $5.98M↑ | $5.71M↑ | -$246,000 |
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance...